RAMPmedical is a therapy decision support tool that empowers doctors by integrating state-of-the-art research into every treatment choice
We help doctors with their therapy decisions by personalizing the results on each patient.
We support their decisions on diabetes type 2 and arterial hypertension
Exclude dangerous treatments
In order to exclude dangerous therapies, RAMPmedical uses patient data and diagnosis.
The software allows doctors to avoid drug interactions and filter by laboratory values. It highlights the contraindications based on the patients informations.
Contraindications based on:
Drug-drug interaction check
Find the best therapy
The software present all the authorized therapies in Europe and several non-drug therapies. It allows doctors to understand evidence matched with patient specificities to find the decide for the best treatment.
Several endpoints presented to compare therapies
Learn about off-label uses.
Details of therapy outcomes.
AI SUPPORTED HIGH-LEVEL SCIENCE
The software respects the Deutsche Diabetes Gesellschaft, the European Association for the Study of Diabetes, and the American Diabetes Association guidelines.
Each value presented on the software is based on scientific evidence. There is a score to assess the reliability of each of the sources, to allow the combination of outcomes in general with weighted average. It also includes baselines characteristics.
Scientific evidence behind the values indicated by colors.
(Evidence is based on the amount and quality of reports or studies)
Differentiation of publications based on evidence.
- Study details to learn the sources.
Seamless integration into doctor’s workflow
RAMPmedical software is integrated into the EHR. This means that the solution runs in the background. If there is some alert that concern the doctor (for example: he is prescribing a dangerous therapy), a warning will appear.
Based on the new input: the selection of a therapy or new laboratory value.
Warnings customized for each case
Explanation of measure to take
List of contraindications for the treatments that might not have been noted into the original platform